232 related articles for article (PubMed ID: 36546424)
1. Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia.
Wang L; Liu S; Luo J; Mo Q; Ran M; Zhang T; Li X; Zou W; Mei Q; Chen J; Yang J; Zeng J; Huang F; Wu A; Zhang C; Wu J
Haematologica; 2023 May; 108(5):1394-1411. PubMed ID: 36546424
[TBL] [Abstract][Full Text] [Related]
2. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling.
Lebois M; Dowling MR; Gangatirkar P; Hodgkin PD; Kile BT; Alexander WS; Josefsson EC
J Thromb Haemost; 2016 Sep; 14(9):1882-7. PubMed ID: 27344013
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a novel megakaryopoiesis enhancer, ingenol, promoting thrombopoiesis through PI3K-Akt signaling independent of thrombopoietin.
Wang L; Zhang T; Liu S; Mo Q; Jiang N; Chen Q; Yang J; Han YW; Chen JP; Huang FH; Li H; Zhou J; Luo JS; Wu JM
Pharmacol Res; 2022 Mar; 177():106096. PubMed ID: 35077844
[TBL] [Abstract][Full Text] [Related]
4. Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia.
Shin J; Kim MJ; Quan X; Kim JW; Lee S; Park S; Jeong JY; Yea K
BMC Cancer; 2023 May; 23(1):490. PubMed ID: 37259024
[TBL] [Abstract][Full Text] [Related]
5. The role of platelet factor 4 in radiation-induced thrombocytopenia.
Lambert MP; Xiao L; Nguyen Y; Kowalska MA; Poncz M
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1533-40. PubMed ID: 21740995
[TBL] [Abstract][Full Text] [Related]
6. DMAG, a novel countermeasure for the treatment of thrombocytopenia.
Lin J; Zeng J; Liu S; Shen X; Jiang N; Wu YS; Li H; Wang L; Wu JM
Mol Med; 2021 Nov; 27(1):149. PubMed ID: 34837956
[TBL] [Abstract][Full Text] [Related]
7. Milestones in understanding platelet production: a historical overview.
Kuter DJ
Br J Haematol; 2014 Apr; 165(2):248-58. PubMed ID: 24528208
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin is a major regulator of thrombopoiesis in thrombopoietin-dependent and -independent contexts.
Hacein-Bey-Abina S; Estienne M; Bessoles S; Echchakir H; Pederzoli-Ribeil M; Chiron A; Aldaz-Carroll L; Leducq V; Zhang Y; Souyri M; Louache F; Abina AM
Exp Hematol; 2020 Aug; 88():15-27. PubMed ID: 32721504
[TBL] [Abstract][Full Text] [Related]
9. Novel chemical-structure TPOR agonist, TMEA, promotes megakaryocytes differentiation and thrombopoiesis via mTOR and ERK signalings.
Jiang X; Sun Y; Yang S; Wu Y; Wang L; Zou W; Jiang N; Chen J; Han Y; Huang C; Wu A; Zhang C; Wu J
Phytomedicine; 2023 Feb; 110():154637. PubMed ID: 36610353
[TBL] [Abstract][Full Text] [Related]
10. Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation.
Ng AP; Kauppi M; Metcalf D; Hyland CD; Josefsson EC; Lebois M; Zhang JG; Baldwin TM; Di Rago L; Hilton DJ; Alexander WS
Proc Natl Acad Sci U S A; 2014 Apr; 111(16):5884-9. PubMed ID: 24711413
[TBL] [Abstract][Full Text] [Related]
11. Thrombocytopenia in c-mpl-deficient mice.
Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
[TBL] [Abstract][Full Text] [Related]
12. Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.
Deutsch VR; Tomer A
Br J Haematol; 2013 Jun; 161(6):778-93. PubMed ID: 23594368
[TBL] [Abstract][Full Text] [Related]
13. Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia.
Zhou L; Ni C; Liao R; Tang X; Yi T; Ran M; Huang M; Liao R; Zhou X; Qin D; Wang L; Huang F; Xie X; Wan Y; Luo J; Wang Y; Wu J
Elife; 2024 Apr; 13():. PubMed ID: 38573820
[TBL] [Abstract][Full Text] [Related]
14. Photobiomodulation therapy for thrombocytopenia by upregulating thrombopoietin expression via the ROS-dependent Src/ERK/STAT3 signaling pathway.
Wang Q; Chang H; Shen Q; Li Y; Xing D
J Thromb Haemost; 2021 Aug; 19(8):2029-2043. PubMed ID: 33501731
[TBL] [Abstract][Full Text] [Related]
15. Thrombopoietin from beginning to end.
Hitchcock IS; Kaushansky K
Br J Haematol; 2014 Apr; 165(2):259-68. PubMed ID: 24499199
[TBL] [Abstract][Full Text] [Related]
16. Xanthotoxin, a novel inducer of platelet formation, promotes thrombocytopoiesis via IL-1R1 and MEK/ERK signaling.
Lai J; Li Y; Ran M; Huang Q; Huang F; Zhu L; Wu Y; Zou W; Xie X; Tang Y; Yang F; Wu A; Ge G; Wu J
Biomed Pharmacother; 2023 Jul; 163():114811. PubMed ID: 37156117
[TBL] [Abstract][Full Text] [Related]
17. Induction of megakaryocytopoiesis and thrombocytopoiesis by JTZ-132, a novel small molecule with thrombopoietin mimetic activities.
Inagaki K; Oda T; Naka Y; Shinkai H; Komatsu N; Iwamura H
Blood; 2004 Jul; 104(1):58-64. PubMed ID: 15001470
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the serum concentration of thrombopoietin in thrombocytopenic NF-E2 knockout mice.
Shivdasani RA; Fielder P; Keller GA; Orkin SH; de Sauvage FJ
Blood; 1997 Sep; 90(5):1821-7. PubMed ID: 9292514
[TBL] [Abstract][Full Text] [Related]
19. Inherited thrombocytopenia: novel insights into megakaryocyte maturation, proplatelet formation and platelet lifespan.
Johnson B; Fletcher SJ; Morgan NV
Platelets; 2016 Sep; 27(6):519-25. PubMed ID: 27025194
[TBL] [Abstract][Full Text] [Related]
20. Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: insight into the regulation of platelet production.
Chang M; Suen Y; Meng G; Buzby JS; Bussel J; Shen V; van de Ven C; Cairo MS
Blood; 1996 Nov; 88(9):3354-62. PubMed ID: 8896400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
